Related Experiment Video
Updated: May 28, 2026

07:41
Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms
Published on: August 4, 2023
Temporal Trends in Carbapenem-Resistant Acinetobacter baumannii Isolation Rates at a Regional Hospital in Central
Ying-Ju Chen1, Tze-Kiong Er1,2,3
1Division of Laboratory Medicine, Asia University Hospital, Asia University, Taichung 41354, Taiwan.
Antibiotics (Basel, Switzerland)
|May 27, 2026
Summary
Carbapenem-resistant Acinetobacter baumannii (CRAB) rates remained high post-pandemic, persisting at elevated levels in hospitals. Intensive care units (ICUs) require focused infection control and antimicrobial stewardship to manage this persistent threat.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Hospital Epidemiology
Background:
- Carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical nosocomial pathogen associated with high mortality, especially in intensive care units (ICUs).
- The long-term impact of the pandemic on institutional CRAB burden requires further investigation at the single-hospital level.
Purpose of the Study:
- To assess the persistence and trends of CRAB isolation rates at a regional teaching hospital from 2020 to 2024.
- To analyze the distribution of CRAB isolates between ICU and non-ICU settings over time.
Main Methods:
- Retrospective observational study of clinical Acinetobacter baumannii complex isolates.
- Classification of isolates as CRAB based on resistance to imipenem or meropenem.
- Analysis of annual and monthly isolation rates, and ICU vs. non-ICU distribution.
Main Results:
- Over 58% (340/582) of Acinetobacter baumannii isolates were CRAB.
- Annual CRAB isolation rates significantly increased from 2020 to 2021 and remained elevated.
- CRAB proportion in ICUs peaked in 2022 but showed no significant overall trend, with wide monthly variations.
Conclusions:
- CRAB isolation rates have remained persistently high following the acute pandemic phase.
- ICUs are a key area for targeted infection prevention and antimicrobial stewardship programs to combat CRAB.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
